Gene · 5962
Papers3,092
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,092
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular vesicles and melanoma: New perspectives on tumor microenvironment and metastasis. | Front Cell Dev Biol | 2022 | 36704194 | PubTator, text mining | PubMed |
| Negative Molecular Diagnostics in Non-Syndromic Hearing Loss: What Next? | Genes (Basel) | 2022 | 36672845 | PubTator, text mining | PubMed |
| Immunoregulatory Role of the Mechanosensitive Ion Channel Piezo1 in Inflammation and Cancer. | Molecules | 2022 | 36615408 | PubTator, text mining | PubMed |
| RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review. | Int J Mol Sci | 2022 | 36613714 | PubTator, text mining | PubMed |
| Endosomal Sorting Protein SNX27 and Its Emerging Roles in Human Cancers. | Cancers (Basel) | 2022 | 36612066 | PubTator, text mining | PubMed |
Molecular, morphological and functional properties of tunnelling nanotubes between normal and cancer urothelial cells: New insights from the in vitro model mimicking the situation after surgical removal of the urothelial tumor. | Front Cell Dev Biol | 2022 | 36601539 | PubTator, text mining | PubMed |
| The molecular basis of the dichotomous functionality of MAP4K4 in proliferation and cell motility control in cancer. | Front Oncol | 2022 | 36568222 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Drug Targets and Delivery Vehicles for Cancer Therapy. | Pharmaceutics | 2022 | 36559315 | PubTator, text mining | PubMed |
| Translational Results of Zo-NAnTax: A Phase II Trial of Neoadjuvant Zoledronic Acid in HER2-Positive Breast Cancer. | Int J Mol Sci | 2022 | 36555156 | PubTator, text mining | PubMed |
| Activated PyK2 and Its Associated Molecules Transduce Cellular Signaling from the Cancerous Milieu for Cancer Metastasis. | Int J Mol Sci | 2022 | 36555115 | PubTator, text mining | PubMed |
| Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells. | Cells | 2022 | 36552728 | PubTator, text mining | PubMed |
| Unconventional Myosins from Caenorhabditis elegans as a Probe to Study Human Orthologues. | Biomolecules | 2022 | 36551317 | PubTator, text mining | PubMed |
| Native holdup (nHU) to measure binding affinities from cell extracts. | Sci Adv | 2022 | 36542723 | PubTator, text mining | PubMed |
| Role of Ezrin in Asthma-Related Airway Inflammation and Remodeling. | Mediators Inflamm | 2022 | 36530558 | PubTator, text mining | PubMed |
| Monoallelic loss of the F-actin-binding protein radixin facilitates startle reactivity and pre-pulse inhibition in mice. | Front Cell Dev Biol | 2022 | 36518539 | PubTator, text mining | PubMed |
| 3D Electron-Rich ZIF-67 Coordination Compounds Based on 2-Methylimidazole: Synthesis, Characterization and Effect on Thermal Decomposition of RDX, HMX, CL-20, DAP-4 and AP. | Molecules | 2022 | 36500463 | PubTator, text mining | PubMed |
| Multi-Omics Immune Interaction Networks in Lung Cancer Tumorigenesis, Proliferation, and Survival. | Int J Mol Sci | 2022 | 36499305 | PubTator, text mining | PubMed |
Global Transcriptional Profiling of Granulosa Cells from Polycystic Ovary Syndrome Patients: Comparative Analyses of Patients with or without History of Ovarian Hyperstimulation Syndrome Reveals Distinct Biomarkers and Pathways. | J Clin Med | 2022 | 36498516 | PubTator, text mining | PubMed |
| The Dual Role of PDCD10 in Cancers: A Promising Therapeutic Target. | Cancers (Basel) | 2022 | 36497468 | PubTator, text mining | PubMed |
| Case Report: Mutations in JAK3 causing severe combined immunodeficiency complicated by disseminated Bacille Calmette-Guérin disease and Pneumocystis pneumonia. | Front Immunol | 2022 | 36466884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5962/papers?page=17